Suchergebnisse - "Adult"

PubPharm (7)

1

Trastuzumab emtansine for residual invasive HER2-positive breast cancer

enthalten in: The New England journal of medicine | 2019

von Minckwitz, G. | Huang, C. | Mano, M. | +26

2

Whole body bone SPET/CT can successfully replace the conventional bone scan in breast cancer patients. A prospective study of 257 patients

enthalten in: Hellenic journal of nuclear medicine | 10 August 2018

von Mavriopoulou, E. | Zampakis, P. | Smpiliri, E. | +5

3

Long-term efficacy analysis of the randomised, phase II TRYPHAENA cardiac safety study : evaluating pertuzumab and trastuzumab plus standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer

enthalten in: European journal of cancer | January 2018

von Schneeweiss, A. | Chia, S. | Hickish, T. | +6

4

Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer : results from AVADO

enthalten in: European journal of cancer | 15 July 2011

von Pivot, X. | Schneeweiss, A. | Verma, S. | +8

5

First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active : results of the MONICA trial

enthalten in: European journal of cancer | 2010 Aug 24

von Kaufmann, M. | Maass, N. | Costa, S. | +14

6

Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases

enthalten in: Human mutation | 2010

von Catucci, I. | Yang, R. | Verderio, P. | +21

7

Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer

enthalten in: Journal of clinical oncology | July 10 2010

von Miles, D. | Chan, A. | Dirix, L. | +13

1
[1]